questionText: To ask the Secretary of State for Health and Social Care, what discussions his Department has had discussions with (a) NICE and (b) Servier on the barriers to approving Vorasidenib for use by the NHS for the treatment of low glade glioma.
answerText: Department officials regularly speak with colleagues in the National Institute for Health and Care Excellence (NICE) to discuss a range of issues, including the status of individual appraisals. As NICE is an independent body, it would not be appropriate f...
heading: Vorasidenib